Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist, which means it activates both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual action helps to:
– Significantly reduce hunger and enhance feelings of fullness.
– Slow gastric emptying, leading to longer-lasting satiety after meals.
– Improve insulin sensitivity and lower blood glucose levels by enhancing insulin secretion and reducing glucagon levels.
Tirzepatide is effective for weight management and improving glycemic control in individuals with type 2 diabetes. Clinical studies have shown substantial weight loss and improvement in metabolic health with tirzepatide treatment.
Available Dosages:
2.5 mg | 5 mg | 7.5 mg | 10 mg | 12.5 mg | 15 mg |
Reviews
There are no reviews yet.